Table of Contents
ISRN Psychiatry
Volume 2014 (2014), Article ID 904829, 7 pages
http://dx.doi.org/10.1155/2014/904829
Clinical Study

Ziprasidone as Adjunctive Therapy in Severe Bipolar Patients Treated with Clozapine

Dipartimento di Medicina Clinica e Sperimentale, Sezione di Psichiatria, Università di Pisa, Azienda Ospedaliero-Universitaria Pisana, Via Roma, No. 67, 56126 Pisa, Italy

Received 19 January 2014; Accepted 13 February 2014; Published 7 April 2014

Academic Editors: C. M. Beasley and S. Khanna

Copyright © 2014 Natalia Bartolommei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Aim. To confirm the efficacy and tolerability of ziprasidone as adjunctive therapy in bipolar patients partially responding to clozapine or with persisting negative symptoms, overweight, or with metabolic syndrome. Methods. Eight patients with psychotic bipolar disorder were tested with the BPRS, the HAM-D, and the CGI at T0 and retested after 2 weeks (T1). Plasma clozapine and norclozapine levels and BMI were tested at T0 and T1. Results. Ziprasidone was well tolerated by all the patients. BPRS and HAM-D scores were reduced in all patients. BMI was reduced in patients with a BMI at T0 higher than 25. Plasma levels of clozapine and norclozapine showed an irregular course.